Global Ezetimibe Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Ezetimibe Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Ezetimibe is a drug that lowers plasma cholesterol levels. It acts by decreasing cholesterol absorption in the small intestine. It may be used alone (marketed as Zetia or Ezetrol), when other cholesterol-lowering medications are not tolerated, or together with statins (e.g., ezetimibe/simvastatin, marketed as Vytorin or Inegy) when statins alone do not control cholesterol.
Ezetimibe report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Ezetimibe market is projected to reach US$ 460.8 million in 2029, increasing from US$ 315 million in 2022, with the CAGR of 6.1% during the period of 2024 to 2029. Demand from Adult and Children are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Ezetimibe industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Ezetimibe key manufacturers include Merck, Teva, Zydus Pharmaceuticals, Amneal Pharmaceuticals, Alkem Laboratories, APOTEX, Sandoz, Glenmark Pharmaceuticals and Mylan Pharmaceuticals, etc. Merck, Teva, Zydus Pharmaceuticals are top 3 players and held % sales share in total in 2022.
Ezetimibe can be divided into 5mg, 10mg, 20mg and 40mg, etc. 5mg is the mainstream product in the market, accounting for % sales share globally in 2022.
Ezetimibe is widely used in various fields, such as Adult and Children, etc. Adult provides greatest supports to the Ezetimibe industry development. In 2022, global % sales of Ezetimibe went into Adult filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ezetimibe market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Merck
Teva
Zydus Pharmaceuticals
Amneal Pharmaceuticals
Alkem Laboratories
APOTEX
Sandoz
Glenmark Pharmaceuticals
Mylan Pharmaceuticals
Aurobindo Pharma
Accord Healthcare
Segment by Type
5mg
10mg
20mg
40mg
80mg
Adult
Children
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Ezetimibe market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Ezetimibe, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Ezetimibe industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Ezetimibe in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Ezetimibe introduction, etc. Ezetimibe Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Ezetimibe market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Ezetimibe report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Ezetimibe market is projected to reach US$ 460.8 million in 2029, increasing from US$ 315 million in 2022, with the CAGR of 6.1% during the period of 2024 to 2029. Demand from Adult and Children are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Ezetimibe industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Ezetimibe key manufacturers include Merck, Teva, Zydus Pharmaceuticals, Amneal Pharmaceuticals, Alkem Laboratories, APOTEX, Sandoz, Glenmark Pharmaceuticals and Mylan Pharmaceuticals, etc. Merck, Teva, Zydus Pharmaceuticals are top 3 players and held % sales share in total in 2022.
Ezetimibe can be divided into 5mg, 10mg, 20mg and 40mg, etc. 5mg is the mainstream product in the market, accounting for % sales share globally in 2022.
Ezetimibe is widely used in various fields, such as Adult and Children, etc. Adult provides greatest supports to the Ezetimibe industry development. In 2022, global % sales of Ezetimibe went into Adult filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ezetimibe market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Merck
Teva
Zydus Pharmaceuticals
Amneal Pharmaceuticals
Alkem Laboratories
APOTEX
Sandoz
Glenmark Pharmaceuticals
Mylan Pharmaceuticals
Aurobindo Pharma
Accord Healthcare
Segment by Type
5mg
10mg
20mg
40mg
80mg
Segment by Application
Adult
Children
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Ezetimibe market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Ezetimibe, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Ezetimibe industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Ezetimibe in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Ezetimibe introduction, etc. Ezetimibe Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Ezetimibe market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.